Penumbra
PEN
#1848
Rank
$8.91 B
Marketcap
$232.39
Share price
1.25%
Change (1 day)
16.96%
Change (1 year)
Categories
Penumbra, Inc., is an American company that develops, manufactures and sells medical devices for neurovascular and vascular medicine applications.

P/S ratio for Penumbra (PEN)

P/S ratio as of November 2024 (TTM): 7.66

According to Penumbra's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 8.08. At the end of 2024 the company had a P/S ratio of 6.39.

P/S ratio history for Penumbra from 2015 to 2024

PS ratio at the end of each year

Year P/S ratio Change
20246.39-30.29%
20239.17-8.04%
20229.97-30.54%
202114.426.63%
202011.37.95%
201910.511.05%
20189.46-1.15%
20179.5724.8%
20167.67-11.31%
20158.65

P/S ratio for similar companies or competitors

Company P/S ratio P/S ratio differencediff. Country
5.10-33.45%๐Ÿ‡บ๐Ÿ‡ธ USA
4.34-43.34%๐Ÿ‡บ๐Ÿ‡ธ USA